• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

ImmunityBio, Inc.

ImmunityBio, Inc.

Public
IBRX
United States
SectorHealthcare
CountryUnited States
Market cap8.31B
ImmunityBio, Inc.,A clinical-stage immunotherapy company developing advanced cell and gene therapies designed to strengthen the immune system against cancer and infectious diseases.

Where to buy ImmunityBio, Inc. (IBRX)

IBRX trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare